Cancer cells reprogram their metabolism, and this metabolic reprogramming in cancer cells is regulated by several oncogenic genes, including the PI3K/Akt, Myc, or hypoxia-inducible factor (HIF) that serve to increase glucose uptake, glycolysis, and transcription of LDHA [6–10]. This evidence concerns the gene AKT1 and cancer.